13:18:36 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Oct. 7, 2015

2015-10-07 20:49 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 3.99 points to 542.68 Wednesday. Robert Thast and Paul Larkin's halted capital pool shell, Capstream Ventures Inc. (CSP), has found another target for its portfolio as it plans to become a tech investment company. The shell will lend $350,000 (U.S.) to Innovega Inc., which is developing video eyewear technology. The loan will be convertible, but the companies have not yet disclosed those terms.

Innovega is a company in Bellevue, Wash., that is developing what it calls the iOptik platform. This allows users to put on a special pair of contact lenses, as well as an accompanying pair of glasses, that offer high-resolution augmented reality displays. Innovega needs clearance from the FDA to sell this gadget because it requires the use of contact lenses, and after that the company hopes to license its technology to other businesses. Deciphering the techno-babble that describes the company's product is far from simple. In short, the simple act of wearing the lenses does nothing. Users may be disappointed to discover they also need an accompanying pair of glasses. Once wearing these, the user sees a high-resolution digital display, allowing access to the Internet, as well as the rest of the real world. Innovega says it already has a working prototype and it has shown its product at various trade shows, but for now this firm is no more than a researcher without sales.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed